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Abstract
Background: Incorrect segregation of whole chromosomes or parts of chromosome leads to
aneuploidy commonly observed in cancer. The correct centrosome duplication, assuring assembly
of a bipolar mitotic spindle, is essential for chromosome segregation fidelity and preventing
aneuploidy. Alteration of p53 and pRb functions by expression of HPV16-E6 and E7 oncoproteins
has been associated with centrosome amplification. However, these last findings could be the result
of targeting cellular proteins in addition to pRb by HPV16-E7 oncoprotein. To get a more detailed
picture on the role of pRb in chromosomal instability and centrosome amplification, we analyzed
the effects of the acute loss of retinoblastoma gene function in primary conditional Rb deficient
mouse embryonic fibroblasts (MEFs). Moreover, since pRb is a transcriptional repressor,
microarray analysis was done on pRb-competent and pRb-deficient MEFs to evaluate changes in
expression of genes for centrosome homeostasis and for correct mitosis.
Results: Acute loss of pRb induces centrosome amplification and aneuploidy in the vast majority
of cells analyzed. A time course analysis shows a decrease of cells with amplified centrosomes after
40 days from the adenoviral infection. At this time only 12% of cells still show amplified
centrosomes. Interestingly, cells with pRb constitutive loss show a similar percentage of cells with
amplified centrosomes. DNA-Chip analyses in MEFs wt (mock infected) and pRb depleted (Ad-Cre
infected) cells reveal differential expression of genes controlling both centrosome duplication and
mitotic progression.
Conclusion: Our findings suggest a direct link between pRb status, centrosome amplification and
chromosomal instability, and define specific mitotic genes as targets whose gene expression has to
be altered to achieve or maintain aneuploidy.
Background
Aneuploidy is considered a common feature of tumors
and early stage carcinomas. Aneuploidy and its underly-
ing cause (CIN) could be considered a prerequisite in
tumor initiation/progression and like alterations in sign-
aling pathways it is believed essential for tumorigenesis
[1,2]. However, the molecular defects underlying aneu-
ploidy and whether it is a cause or a consequence of the
tumor phenotype are not completely clear. At least two
possible causes of aneuploidy could be suggested: muta-
tion/alteration in genes encoding spindle checkpoint pro-
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numbers.
Some studies suggest that aneuploidy in cancer cells could
arise from defects in the mitotic spindle checkpoint. This
mitotic checkpoint monitors that in metaphase, all chro-
mosomes are properly aligned and attached to the mitotic
spindle before progressing to anaphase. Although in
human and murine cells mutations of some of these
mitotic genes such as: hBUB1, hSecurin, hMAD2 and
hBUBR1 induced aneuploidy in dividing diploid cells
over several generations, they were rarely mutated in
human tumors [3-7]). Recently, it was reported a heredi-
tary mutation of the hBUBR1 gene in patients with mosaic
variegated aneuploidy (MVA) a rare genetic disease with
increased cancer risk [8]. Also, MAD2 overexpression was
associated with stable inactivation of the retinoblastoma
tumor suppressor and consequently E2F-1 activation [9].
Alternatively, aneuploidy could arise from an initial
abnormal chromosome complement that in turn triggers
chromosome missegregation and genetic instability [1].
Previously, we showed that transient polyploidization
caused by DNA re-replication could be a trigger for aneu-
ploidy in human cells [10]. Moreover, after treatments
with anti-mitotic drugs both human and murine pRb defi-
cient cells displayed perpetual aneuploidy and amplified
centrosomes [11] suggesting that deregulation of cell cycle
progression and alteration in centrosome numbers could
be implicated in chromosomal instability.
Loss of centrosome duplication control will often create
multipolar spindles that in turn could be responsible for
the incorrect segregation of whole chromosomes leading
to aneuploidy. Centrosome duplication is coupled to
DNA replication and systems of constraints ensure that
centrosome duplication occurs during S phase once and
only once. In particular, the activation of cyclin E-Cdk2
(cyclin-dependent kinase 2) complex at the G1/S phase
transition of the cell cycle allows both DNA replication
and centrosome duplication to proceed. [12]. Centro-
some amplification was associated with genetic instability
in prostate [13] and breast cancer [14] as well as in prein-
vasive cancer lesions [15]. The observation made in
human keratinocytes that centrosome amplification
occurs following expression of the HPV16 E6 and E7
oncoproteins [16] suggests a role in this process for the
tumor-suppressors p53 and pRb. Also, centrosome ampli-
fication induced by a transient G1/S arrest because of the
presence of Hydroxyurea, generated aneuploidy both in
human and MEFs with pRb dysfunction [11]. However, it
is still controversial whether p53 loss/inactivation plays a
direct role in centrosome amplification [17] and chromo-
some instability [18]. Indeed, recently it has been
reported that p53 deficient cells need cyclin E over-expres-
sion, a target of E2F transcription factor, to induce chro-
mosome instability and centrosome amplification [19].
This suggests that pRb dysfunction, resulting in activation
of the E2F family transcription factors, could be crucial in
centrosome amplification and chromosome instability.
To get additional clues on the role of pRb in CIN we ana-
lyzed the effects of acute loss of retinoblastoma gene func-
tion on centrosomes and aneuploidy in primary
conditional Rb deficient Mouse Embryonic Fibroblasts
(MEFs). This conditional knockout system permits us to
assess the effects of acute loss of the retinoblastoma gene
by the Cre-lox-mediated excision of Rb's exon 19. In addi-
tion by DNA microarray analysis of these pRb deficient
cells we found altered expression of mitotic genes that
could account for chromosomal instability associated
with centrosome alterations. Our results suggest a direct
link between pRb status, centrosome amplification and
altered expression of genes necessary for the correct mito-
sis progression in triggering aneuploidy.
Results
Centrosome amplification after acute loss of pRb in 
primary murine fibroblasts
To evaluate the effects of Rb acute loss on centrosomes we
used Mouse Embryonic Fibroblasts (MEFs) carrying con-
ditional Rb alleles (RbLoxP/LoxP) in which two LoxP sites are
inserted into the introns surrounding exon 19 of the Rb
gene [34]. Exponentially growing MEFs (MEF RbLoxP/LoxP)
were infected with adenoviruses expressing the Cre
recombinase (Ad-Cre) in order to generate cells with trun-
cated pRb (Rb-/-), by excision of exon 19, that are function-
ally equivalent to Rb null cells. As a control RbLoxP/LoxP MEFs
were infected with adenoviruses that did not express the
Cre transgene (pRb proficient, indicated as Ad-empty
MEFs). Western-blot experiments (Figure 1A) showed that
in RbLoxP/LoxP MEFs the pRb protein was no longer detecta-
ble as soon as 3 days after infection with Ad-Cre in com-
parison to both uninfected cells and cells infected with
adenoviruses that did not express the Cre recombinase.
Acute loss of pRb (3 days) in these murine cells resulted in
high percentage of cells (55 %) with centrosome amplifi-
cation as seen by immunocytochemistry against γ-tubulin
(Figure 1B). Actual centrosome reduplication was con-
firmed by immunostaining of centrin (Figure 1B). In addi-
tion detection of β-tubulin showed the presence of altered
mitotic spindles in cells acutely depleted of pRb (Figure
1B). A time course analysis of the cells acutely depleted of
pRb showed (Figure 1D) that the number of cells with
amplified centrosomes decreased over time and after 40
days from the transfection only 12% of cells still showed
amplified centrosomes. Cells with pRb constitutive loss
showed a similar number (10%) of cells with amplified
centrosomes. These results are similar to those previously
reported in p53-/- MEFs that have about 30% of cells withPage 2 of 11
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Centrosome amplification in MEFs after pRb acute lossFigu e 1
Centrosome amplification in MEFs after pRb acute loss. (A) Western blot analysis showing the level of pRb expression 
after 3 and 30 days from the adenoviral infection: RbLoxP/LoxP MEF uninfected (lane 1), infected with the empty adenoviral vector 
(lane 2) and with the Ad-Cre at 3 (lane 3) and 30 days (lane 4). (B) Control MEFs (Rb+/+) showed 1 or 2 centrosomes, on the 
contrary MEFs acutely depleted of pRb (Rb-/-) showed the presence of supernumerary centrosomes (arrowheads). The 
number of centrosomes per cell was scored by microscope. Centrosomes were revealed by  tubulin and centrin detection 
(green) and nuclei were stained with DAPI (blue). (C) Presence of coalescent centrosomes forming pseudo-bipolar spindles in 
pRb deficient MEFs as shown by β- and γ-tubulin detection. (D) Time course analysis showing a decrease of cells with amplified 
centrosomes at 40 days from adenoviral infection. Histograms show the percentage of cells with 1, 2 or more than two cen-
trosomes. An average of 100 cells were analyzed for each time point. Each bar indicates mean + s.e. of at least three independ-
ent experiments. (E) Representative FACScan profiles of cell cycle distribution after 30 days from the adenoviral infection in 
primary murine fibroblasts.
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Acute loss of Rb leads to chromosome instability and increases MPM2 positive cellsFigure 2
Acute loss of Rb leads to chromosome instability and increases MPM2 positive cells. (A) pRb deficient MEFs show 
increased aneuploid metaphases both hypodiploid (<40 chromosomes) and hyperdiploid (>40 chromosomes). Each bar indi-
cates mean + s.e. of three independent experiments. (B) pRb deficient MEFs have increased percentage of cells with micronu-
clei. An average of 100 cells were analyzed for each time point, each bar represents mean + s.e. of two experiments. (C) MEFs 
acutely depleted of pRb (Rb-/-) have increased number of mitotic cells with multiple centrosomes (arrowheads). Mitotic cells 
and centrosomes were revealed by using primary antibodies against MPM2 (Mitotic Protein Monoclonal) and γ-tubulin, that 
were detected by FITC (green) and TRITC (red) conjugated secondary antibody respectively. (D) Histograms indicating the 
percentage of MPM2 positive cells in pRb competent and deficient MEFs. An average of 100 cells were analyzed for each time 
point, each bar represents mean + s.e. of at least two experiments. (E) Western blot analysis showing the amount of MAD2 
protein after 3 days from the adenoviral infection: RbLoxP/LoxP MEF uninfected (lane 1), infected with the empty adenoviral vec-
tor (lane 2) and with the Ad-Cre vector (lane 3).
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longed culture almost of the cells showed a normal cen-
trosome complement (clonal adaptation) [20]. FACScan
analyses after Ad-Cre infection showed lack of cells with
DNA content less than 2N (Figure 1E) suggesting that in
these cells apoptosis has not taking place. This is consist-
ent with previous findings that in murine cells pRb abro-
gation doesn't induce apoptosis [21].
These results underline a different effect of acute versus
chronic loss of pRb and that the majority of cells with
amplified centrosomes are not maintained during growth
in culture most likely because of chromosomal instability
triggered by amplified centrosomes. We also scored a frac-
tion of pRb depleted cells showing clusters of multiple
centrosomes at each spindle pole (Figure 1C) that could
be a safeguard mechanism by which bipolarity of the
spindle is maintained and the cells are unlikely to acquire
extensive chromosomal alterations.
Acute loss of pRb in primary murine fibroblasts is 
associated with aneuploidy
Centrosome amplification observed after acute loss of
pRb in MEFs might be responsible for chromosomal mis-
segregation and successive aneuploidy. To this aim we
examined whether MEFs with acute depletion of pRb had
acquired chromosomal instability by carrying out conven-
tional cytogenetic analyses. Alterations in the normal
number of chromosomes were frequently observed in
MEFs acutely depleted of pRb but not in their wild type
parental counterpart. After 7 days from Ad-Cre infection
30% of scored metaphases were aneuploid, both
hypodiploid and hyperdiploid (Figure 2A). The percent-
age of aneuploid metaphases increased to 45–50% after
30 days from Ad-Cre infection suggesting the occurrence
of perpetual aneuploidy in these cells. In addition, micro-
scopic examination at 72 hours revealed that these Rb
'knockout' cells showed a significant increase in the per-
centage (20%) of cells with micronuclei (Figure 2B) as
well as lobulated nuclei. The presence of micronuclei
reveals segregation defects and it may explain the genera-
tion of hypodiploid mitoses after pRb acute loss. FACScan
analyses of wild type and of pRb acutely depleted MEFs
(Figure 1E) showed a similar distribution of cells in the
G1/S and G2/M phases suggesting that loss of pRb did not
influence the cell cycle progression. However, specific
evaluation of mitotic cells after 72 hours from AdCre
infection by MPM2 staining (Figure 2C), an antibody that
recognizes mitotic proteins, revealed a higher number of
positive (mitotic) cells (15%) in Rb depleted MEFs in
comparison to wild type MEFs (Figure 2D). The increased
mitotic index suggests that the duration of mitosis in these
cells could be prolonged by activation of the mitotic
checkpoint as suggested by MAD2 over-expression in
these cells (Figure 2E).
Presence of significant changes in gene expression in cells 
acutely depleted of pRb
The results above suggest that pRb acute loss in primary
murine fibroblasts can both induce centrosome amplifi-
cation and chromosomal instability (aneuploidy). In
order to better understand whether loss of pRb affects
expression levels of specific genes underlying centrosome
amplification and aneuploidy, we used microarray analy-
sis to identify differentially expressed genes in cells
wherein pRb was acutely depleted in respect to gene
expression of control cells.
Independent cultures of asynchronously growing age
matched MEFs both pRb proficient and deficient were uti-
lized to isolate RNA. This RNA was then subjected to
microarray analyses on the Affymetrix GeneChip® MGU-
74A Array platform. The data of the different arrays were
compared by means of normalization techniques and
clustered to group similar arrays. Differentially expressed
genes (DEG) were selected according to a significance
level and clustered to group genes with similar expression
profiles across the samples. DEGs were then functionally
characterized with several databases, and annotation
terms were ranked based on their statistical relevance.
Finally, a correspondence analysis was performed aimed
at highlighting the most relevant genes for each experi-
mental condition. Only the statistically most significant
annotation terms were selected (p Value ≤ 1e-3) and a
minimum statistical value of 2 was used to narrow the list
of genes modified by pRb loss. From these analyses we
identified 231 individual Affymetrix entries: 186 upregu-
lated and 45 down-regulated [see Additional file 1]. The
GO (Gene Ontology) pathway categories showed that the
majority of up-regulated transcripts belonged to cell cycle,
DNA replication and chromatin assembly. Whereas tran-
scripts with reduced levels were principally associated
with cytoskeleton and basal metabolism (Figure 3). As
expected many of the up-regulated genes were known E2F
targets [see Additional file 1] in particular in the DNA rep-
lication category MCM proteins were strongly upregulated
by pRb loss. Additional genes regulating the DNA replica-
tion complex were also upregulated, including Cdk2 and
cyclin-E that phosphorylate members of the replication
complex and are necessary for centrosome duplication.
These extensive alterations in the DNA replication path-
way reflect a general induction of DNA synthesis. Another
interesting observation was the up-regulation of cdc2 and
cyclin-B, partners of the kinase complex required for pro-
gression into mitosis. In addition pRb loss upregulated
other genes involved in mitosis progression, centrosome
homeostasis and mitotic checkpoint such as Plk1, Brca1
and Stk6 (Aurka), Nek2, Stathmin 1, Ckap2, Pttg1
(Securin), Cdc20, Mad2l1 (Table 1). Most of these genes
are considered critical regulators of cell cycle progression
and centrosome duplication that exhibit aberrant expres-Page 5 of 11
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suggest that the expression differences observed in cells
acutely depleted of pRb could account for the phenotype
observed. In order to confirm these results we chose a sub-
set of genes from the mitotic group and performed quan-
titative Real time RT-PCR analysis to assess whether gene
Functional hierarchies of transcriptsigure 3
Functional hierarchies of transcripts. (A) Overall view of transcript changes. Note that because increased/decreased 
genes may appear multiple times within these hierarchies, the number of genes is relative, not absolute. (B) Comparison of 
expression levels of selected genes between real-time RT-PCR data in MEFs: uninfected (black bars), infected with the empty 
adenoviral vector (white bars) and infected with Ad-Cre (grey bars) and Affymetrix array data (downward diagonal bars).Page 6 of 11
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an accurate picture of the transcription taking place.
Graphic representation of Real time RT-PCR showed that
expression levels were very close to those obtained via
microarray (Figure 3B). Although the fold change values
between groups may differ, transcripts found to be
increased in microarrays were found to be increased in
Real time RT-PCR studies.
Discussion
Centrosome amplification and chromosome instability
(aneuploidy) occur in virtually all solid tumors analyzed
and could be considered early features in tumor initiation
and progression [22]. Gain or loss of chromosomes (ane-
uploidy) could generate in a single step multiple changes
required for tumor initiation and progression. At least two
possible cause of aneuploidy, not mutually exclusive,
could be suggested: defects in genes controlling centro-
some homeostasis and mutations in genes encoding
mitotic checkpoint proteins.
Stable disruption of cell cycle proteins such as pRb, p53,
Brca1, altered expression of Aurora kinases, presence of
the viral oncoproteins HPV16-E7 and HPV16-E6 have
been associated with centrosome amplification. In addi-
tion dysfunction of genes involved in the mitotic check-
point such as Mad2l1 and BUB family members could
lead to chromosomal instability (aneuploidy) facilitating
tumorigenesis.
In mammalian cells DNA replication and centrosome
duplication must be completed successfully before mito-
sis and are tightly regulated by a control network in which
pRb plays an important role. To this regard we showed
that centrosome amplification and perpetual aneuploidy
occurred in MEFs cells stably devoid of pRb only follow-
ing a prolonged G1/S arrest because of exposure to
hydroxyurea [11]. Similar results were recently reported in
normal human cells lacking of p16ink4A, a regulator of pRb
activity, following hydroxyurea treatment [23]. However,
disruption of a checkpoint governed by pRb through inac-
Table 1: Changes in transcript levels of genes associated with mitotic progression after pRb acute loss
Symbol Stat. Value Description Function
Stmn1 11,1 stathmin 1 microtubule depolymerization mitotic spindle assembly
Ckap2 8,74 cytoskeleton associated protein 2 microtubule stabilization
Nusap1 8,45 nucleolar and spindle associated protein 1 positive regulation of mitosis
Prc1 7,06 protein regulator of cytokinesis 1 mitotic spindle midzone associated-Cdk dependent
Ccnf 6,76 cyclin F cell cycle, mitosis
Ccnb2 6,57 cyclin B2 regulation of cell cycle
Anln 6,18 anillin, actin binding protein (scraps homolog, Drosophila) cytokinesis
Cdc20 6,14 cell division cycle 20 homolog (S. cerevisiae) cytokinesis
Smc2l1 6,11 SMC2 structural maintenance of chromosomes 2-like 1 
(yeast)
mitotic chromosome condensation
Ccnb1 5,98 cyclin B1 DNA replication
Smc4l1 5,91 SMC4 structural maintenance of chromosomes 4-like 1 
(yeast)
chromosome segregation and organitation, cytokinesis
Plk4 5,61 polo-like kinase 4 (Drosophila) cell cycle and centrosome homeostasis
Cdc2a 5,45 cell division cycle 2 homolog A (S. pombe) mitotic G2 checkpoint
Mdm2 5,41 transformed mouse 3T3 cell double minute 2 traversing start control point of mitotic cell cycle
Mki67 5,34 antigen identified by monoclonal antibody Ki 67 meiosis, cell proliferation
Rad21 5,08 RAD21 homolog (S. pombe) cytokinesis, DNA repair, apoptosis, mitosis
Cdk2 5,01 cyclin-dependent kinase 2 cytokinesis, cell cycle, mitosis
Stk6 4,95 aurora kinase A cell cycle and centrosome homeostasis
Anapc5 4,81 anaphase-promoting complex subunit 5 cytokinesis, ubiquitin cycle, cell cycle, mitosis
Pttg1 4,54 pituitary tumor-transforming (securin) cell cycle, chromosome segregation, mitosis
Plk1 4,44 polo-like kinase 1 (Drosophila) cell cycle and centrosome homeostasis
Mad2l1 4,38 MAD2 (mitotic arrest deficient, homolog)-like 1 (yeast) mitotic sister chromatid segregation, cytokinesis, mitotic 
spindle checkpoint
Cks2 4,15 CDC28 protein kinase regulatory subunit 2 cytokinesis, cell cycle
Rbbp4 4,11 retinoblastoma binding protein 4 transcription
Ccna2 3,94 cyclin A2 regulation of cell cycle, cytokinesis
Nek2 3,7 NIMA (never in mitosis gene a)-related expressed kinase 2 mitotic sister chromatid segregation, cytokinesis, mitosis
Ccne1 3,11 cyclin E1 regulation of progression through cell cycle, DNA 
replication
Brca1 2,52 Breast Cancer Associated Protein 1 DNA repair, apoptosis, mitosis
Genes are listed by symbol, change in expression level, description and biological function.Page 7 of 11
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ations or to chromosomal instability [24].
Here we demonstrate for the first time that also pRb acute
loss in conditional deficient Rb MEFs resulted in centro-
some amplification and aneuploidy highlighting the
importance of pRb in the control of genetic stability.
These results are consistent with recent findings showing
that p53 deficient cells also need cyclin E over-expression,
a target of the E2F transcription factor, to induce CIN and
centrosome amplification [19]. Moreover, reduction in
hCDC4 protein level by siRNA resulted in a high increase
in cyclin E levels and was associated with spindle dysfunc-
tion and CIN [25]. Conditions that favor disruption of cell
cycle transitions may then contribute to centrosome
amplification that in turn results in chromosomal insta-
bility through assembly of multipolar spindles. Our DNA
microarray analysis showed that several pathways were
affected in cells acutely depleted of pRb. Although it is dif-
ficult to discuss each of them in detail, it is worthwhile to
outline the upregulation of genes involved in centrosome
homeostasis and mitosis progression. In particular DNA
microarray analysis revealed changes in transcripts of
mitotic genes not shown previously, in addition to known
genes under E2F control that define a pRb null phenotype
[26,27]. We found that critical regulators of mitotic pro-
gression and centrosome duplication that harbor onco-
genic activity and exhibit aberrant expression in multiple
tumors such as Plk1, STK6 (Aurora-A), Stathmin 1 and
BRCA1 were upregulated after pRb acute loss. Recently, it
has been shown that activation of the RB-pathway
resulted in the repression of Plk1 promoter activity and
that this action was dependent on the SWI/SNF chromatin
remodeling complex [28]. Also the increase of Stathmin 1
expression levels could play a role in chromosomal insta-
bility in murine cells. In fact recent studies point to Stath-
min 1 as an important mitotic regulator highly expressed
in many cancers that is under transcriptional control of
E2F [29]. Expression of the HPV16-E7 prevented the
down-regulation of Stathmin 1 and led to premature exit
from G2 after genotoxic stress [30]. Thus, functional com-
plexes containing E2F and RB appear to be essential for
repressing expression of critical mitotic regulators. The
increase in the mitotic index of cells acutely depleted of
pRb suggested the activation of the mitotic checkpoint
triggered by MAD2 levels whose increased gene expres-
sion was confirmed by Real time RT-PCR. However, the
concomitant over-expression of important mitotic regula-
tors such as Aurora-A and cdc20 could allow some cells to
override the activated mitotic checkpoint and then result
in aneuploidy [31]. Recently, it was reported that in cells
stably depleted of pRb via RNA interference by short hair-
pin RNAs against Rb transcript increased expression of
MAD2 led to chromosomal instability [9]. The explana-
tion for this paradoxical effect of MAD2 was that part of
the population adapted to the activated checkpoint, and
entered the cell cycle as polyploid cells. This could then
cause chromosome misdistribution in subsequent
mitoses. However, it could be also possible that addi-
tional genetic changes arose during the selection (i.e.
Aurora-A/cdc20 over-expression) and overrode the acti-
vated mitotic checkpoint.
Altogether, our findings strongly suggest that pRb acute
loss resulting in centrosome amplification and likely
affecting expression of G2/M genes other than G1/S genes
could be crucial in CIN.
Conclusion
Centrosome amplification is a frequent event in almost all
types of solid tumors and although it is not completely
clear what cellular factors are responsible for chromo-
some instability associated with initiation of cancer, it is
known that the majority of cancers have mutations in
components of Rb pathway. The effects of pRb acute loss
in primary murine cells seem to link deregulation of cell
cycle progression and alteration in centrosome numbers
and mitotic genes to induce aneuploidy.
Finally, we hypothesize that the loss of pRb triggered cen-
trosome amplification by altering expression of genes
encoding protein for centrosome homeostasis (i.e. cyclin
E, Aurora-A, PLK1, Nek2) and induced defects in compo-
nents of the spindle checkpoint (MAD2) that in turn gave
rise to aneuploidy.
Methods
Cells and cell culture
Mouse Embryonic Fibroblasts (MEFs) with conditional
Rb alleles (RbLoxP/LoxP MEFs) were infected (MOI: 300, that
ensures 90–95% of successful infected fibroblasts) with
the empty vector J-pCA13 or with adenoviruses (Ad-Cre)
expressing the Cre recombinase under control of the
human cytomegalovirus (hCMV) immediate-early pro-
moter to generate MEFs devoid of pRb (Rb-/-). All adeno-
viruses used in this study were replication-deficient (E1
region deleted). Cells were cultured in DMEM supple-
mented with 10% FBS, 100 units/ml penicillin and 0.1
mg/ml streptomycin (Euroclone Ltd UK).
Immunoblot analysis
Cells were lysed in SDS/PAGE sample buffer, protein
extracts were resuspended in loading buffer (0.125 M Tris-
HCl, 4% SDS, 20% Glycerol v/v, 0.2 M dithiothreitol,
0.02% Bromophenol Blue, pH 6.8) and 50 μg of proteins
(as determined by the Bradford assay) were loaded per
lane on a SDS PAGE gel. After gel electrophoresis proteins
were electro transferred onto Immobilon-PVDF mem-
brane (Millipore) blocked in 5% (w/v) no-fat milk in
TBST buffer (10 mM Tris pH8.0, 150 mM NaCl, 0.1%Page 8 of 11
(page number not for citation purposes)
Molecular Cancer 2006, 5:38 http://www.molecular-cancer.com/content/5/1/38Tween 20) at room temperature and incubated overnight
at 4°C with the primary antibody. After washes with TBST
buffer the blot was incubated in horseradish peroxidase-
conjugated secondary antibody (Santa Cruz Biotechnol-
ogy) diluted 1:2000 for 1 hour RT. To detect amount of
pRb and MAD2 proteins blots were probed with mouse
monoclonal antibodies anti pRb (554136, Becton Dickin-
son) and anti MAD2 (Santa Cruz Biotechnology) respec-
tively as recommended by manufacturer. Equal loading of
proteins was evaluated by probing the blots with a mouse
monoclonal antibody β-actin (A53-16 Sigma). Blots were
developed with chemiluminescent reagent (SuperSignal-
West Pico, Pierce Rockford, IL) and exposed to CL-Xpo-
sure film (Pierce Rockford, IL) for 1 to 5 min.
Determination of Ploidy
Asynchronous cells were treated with 0.2 μg/ml colcemid
(Demecolcine, Sigma, St. Louis, MO) for 4 hours. Cells
were harvested by trypsinization, swollen in 75 mM KCl
at 37°C, fixed with 3:1 methanol/acetic acid (v/v), and
dropped onto clean, ice-cold glass microscope slides. The
slides were air-dried and stained with 3% Giemsa in phos-
phate-buffered saline for 10 min. Chromosome numbers
were evaluated using a Zeiss Axioskop microscope under
a 100 × objective. At least 50 metaphases were analyzed at
each time point.
Immunofluorescence microscopy
To detect centrosomes cells (4 × 104) were grown onto
glass coverslips, fixed in methanol at -20°C, permeabi-
lized with 0.1% Triton X (Sigma, St. Louis, MO) and
blocked with 0.1% BSA both at room temperature. Then,
coverslips were incubated with a mouse monoclonal anti-
body against γ-tubulin (Sigma, diluted 1:250 in PBS-BSA
0,1%), centrin (a gift of Prof J. Salisbury, Rochester,
diluted 1:5000 in PBS-BSA 0,1%) or β-tubulin (Sigma,
diluted 1:250 in PBS-BSA 0,1%) overnight at 4°C, washed
in PBS and incubated with a FITC-conjugated goat anti-
mouse IgG secondary antibody (Sigma, diluted 1:100 in
PBS-BSA 0,1%) for 1 hour at 37°C. Nuclei were visualized
with 4', 6-Diamidino-2-phenylindole (DAPI) and exam-
ined on a Zeiss Axioskop microscope equipped for fluo-
rescence; images were captured with a CCD digital camera
(Axiocam, Zeiss) and then transferred to Adobe Pho-
toShop for printing.
RNA preparation for microarray analysis
Total RNA was extracted from MEF cultures by RNAeasy
Mini kit according to the manufacture's instruction (Qia-
gen). RNA was isolated from control cultures (MEF RbLoxP/
LoxP infected with empty adenovirus) at two separated
times and from test cultures (MEF RbLoxP/LoxP infected with
adenoviruses expressing Cre) at three separated times, for
a total of 5 RNA samples for six crosses. Total RNA was
used for double stranded c-DNA synthesis using the
Superscript Choise System (Invitrogen, Life Technologies)
with a (dT)24-T7 promoter region (GGCCAGTGAATTG-
TAATACGACTCACTATAGGGAGGCGG [dT]24). After c-
DNA clean-up, cRNA labeled with biotinylated ribonucle-
otides was synthesized with the BioArray High Yield RNA
transcript labeling kit (Enzo, distributed by Affymetrix,
Inc.). The cRNA was cleaned-up by Gene chip Sample
Cleanup Module (Affymetrix) and fragmented by metal-
induced hydrolysis and used for hybridization with
mouse MGU74A arrays (Affymetrix). C-RNA samples
were hybridized to mouse Affymetrix Chip MGU74A as
recommended by Affymetrix. Hybridization and first
analysis were conducted at Genopolis Consortium
(Milan). DNA chips were scanned with the GeneChip
scanner and signals were processed by using the Gene-
Chip expression analysis algorithm (GCOS, Affymetrix).
Microarray analysis
Four quality checks were performed to verify the quality of
sample preparation and hybridization. First of all for each
sample the percentage of probe sets with Detection call
"Absent" (A) over the total number of probe sets was
determined, as well as for the probe sets with Detection
call "Present" (P). Next for each sample the mean value of
probe set called A and P respectively was determined. This
step of the overall analysis was performed on raw data,
before sample normalization, thus differences reflected
bias that will be eliminated with the next step of the anal-
ysis. Finally the ratios between the expression values for 3'
and 5' end of GAPDH and β-actin transcripts was deter-
mined. This is useful to control the degree of sample deg-
radation. In order to make different chips comparable, it
was necessary to normalize signal intensities, using the
Qspline method, a robust non-linear method for normal-
ization using array signal distribution analysis and cubic
splines. All probe sets called "Absent" (A) over all condi-
tions and replicates were removed (5012). The 95th per-
centile of all the signals of the entire dataset that were
flagged with an absent call is determined and used as a
threshold to remove all the remaining probe sets whose
expression values are always below this value in each sam-
ple (3440). Finally 4036 probe sets remain for the next
analysis steps. PLGEM was used for the selection of differ-
entially expressed genes [32]. The PAM-clustering method
was used to partition the gene expression profiles into k
clusters. The optimal number of clusters is automatically
determined, based on quality scores obtained from differ-
ent trials of clustering. Experimental conditions where
replicates are available are averaged and the logarithm of
the ratio between each exp. cond. and the condition cho-
sen as the baseline are calculated (log Ratios). The similar-
ity of the expression profiles of genes within a cluster
suggests a similarity in their regulation. Even for poorly
annotated genes (e.g. ESTs) a functional hint can be
drawn from the occurrence of known genes within thePage 9 of 11
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(GO) annotations for DEG from each cluster were identi-
fied by determining the probability (p Value) of random
occurrence of GO terms (functional enrichment). Only
the statistically most significant annotation terms are
selected (p Value ≤ 1e-3).
Real time RT-PCR
Some differentially expressed genes were selected for Real
time RT-PCR. The selected sequences (provided by
Affymetrix) associated with the probe sets located on the
array were tested against public databases to confirm the
identity of the genes. Once confirmed, primer were
designed with Primer Express software (Applied Biosys-
tems) choosing amplicons of approximately 70–100 bp.
Total RNA used for synthesis of microarray probes
(above) was reverse-transcribed in a final volume of 100
μL using the High Capacity c-DNA Archive kit (Applied
Biosystems) for 10 minutes at 25°C and 2 hours at 37°C.
For each sample 2 μL of cDNA, corresponding to 100 ng
of reverse transcribed RNA, were analyzed by Real time
RT-PCR (95°C for 15 sec, 60°C for 60 sec repeated for 40
cycles), in triplicate, using the ABI PRISM 7300 instru-
ment (Applied Biosystems). Real time RT-PCR was done
in a final volume of 25 μl comprising 1× Master Mix SYBR
Green (Applied Biosystems) and 0,3 μM of forward and
reverse primers for: MAD2 (Fwd: 5'-GCCGAGTTTTTCT-
CATTTGG-3'; Rev 5'-CCGATTCTTCCCACTTTTCA-3')
[33], Plk1 (Fwd:5'-CTTGGGTATCAGCTGTGT GACAA-3';
Rev 5'-TCAAGGAATTGGGATGGGAG-3'); Aurka (Fwd:5'-
GTTCCC TTCGGTCCGAAAC-3'; Rev 5'-AATCATTTCCG-
GAGGCTG-3'; β-actin (Fwd:5'-ACCGTGAAAGATGAT-
GACCCAGA-3'; Rev 5'-GAGGCATACAGGGA CAGCACA-
3'); BRCA1 (Fwd:5'-CCTTGGCACAGGTGTCCAC-3'; Rev
5' GCCATTGTCCTCTGTCCAGG-3'). Data were analyzed
by averaging triplicates Ct (cycle threshold). Levels of RNA
expression were determined by using the SDS software
version (Applied Biosystems) according to the 2-ΔΔct
method. Levels of RNA expression of selected genes were
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